News & Analysis
|
Feb. 24, 2014
1. To Buy or Not to Buy? Purchasing Decisions in the Clinical Lab.
2. FDA Issues Final Rule on Medical Device Adverse Event Reporting.
3. EndoGastric Solutions to Pay $5M to Settle False Claims, Kickbacks Allegations.
4. Speaker Spotlight: Raji Kumar, Chief Executive Officer, Dallas Medical Center speaking on the topic "Igniting Uncommon Performance in Healthcare".To learn more and register for the May event in Chicago,.
5. Safety of Indian-Produced Drugs Being Questioned.
6. Medisca Recalls L-Citrulline Products, Cites Lack of L-Citrulline.
7. ECRI Names Healthcare Supply Chain Achievement Award Winners.
8. The Need for Support of Stroke-Ready Certification in Rural United States: An Overview.
Visit our other publications: Becker's ASC Review, Becker's Clinical Quality & Infection Control & Becker's Spine Review.
For more news, updates and information on Hospital Supply Chain and Purchasing, "like" Becker's Hospital Review on Facebook!
Learn More About Our Featured E-Weekly Advertisers:
|